{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:08:48Z","timestamp":1760080128316},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,28]],"date-time":"2017-12-28T00:00:00Z","timestamp":1514419200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s12325-017-0655-z","type":"journal-article","created":{"date-parts":[[2017,12,28]],"date-time":"2017-12-28T05:58:36Z","timestamp":1514440716000},"page":"5-11","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["An Emerging Treatment Alternative for Anemia in Chronic Kidney Disease Patients: A Review of Daprodustat"],"prefix":"10.1007","volume":"35","author":[{"given":"Kimberly A.","family":"Becker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,28]]},"reference":[{"key":"655_CR1","unstructured":"Centers for Disease Control and Prevention. Chronic Kidney Disease. CDC.gov. \n                    https:\/\/nccd.cdc.gov\/ckd\/\n                    \n                  . Accessed Sep 18, 2017."},{"issue":"1","key":"655_CR2","doi-asserted-by":"publisher","first-page":"e84943","DOI":"10.1371\/journal.pone.0084943","volume":"9","author":"ME Stauffer","year":"2014","unstructured":"Stauffer ME, Fan T. Prevalence of anemia in chronic kidney disease in the United States. PLoS ONE. 2014;9(1):e84943.","journal-title":"PLoS ONE"},{"issue":"8","key":"655_CR3","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1053\/j.ajkd.2016.12.011","volume":"69","author":"N Gupta","year":"2017","unstructured":"Gupta N, Wish JB. Hypoxia-inducible factor prolyl hydroxylase inhibitors: a potential new treatment for anemia in patients with CKD. Am J Kidney Dis. 2017;69(8):815\u201326.","journal-title":"Am J Kidney Dis"},{"key":"655_CR4","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1093\/ndt\/gft251","volume":"29","author":"J Onken","year":"2013","unstructured":"Onken J, Bregman B, Harrington RA, et al. Ferric carboxymaltose in patients with iron deficiency anemia and impaired renal function: the REPAIR-IDA trial. Nephrol Dial Transplant. 2013;29:833\u201342.","journal-title":"Nephrol Dial Transplant"},{"key":"655_CR5","unstructured":"Epogen [package insert]. Amgen Inc., Thousand Oaks, CA; 1989."},{"key":"655_CR6","unstructured":"Procrit [package insert]. Amgen Inc., Thousand Oaks, CA: 1989."},{"key":"655_CR7","unstructured":"Aranesp [package insert]. Amgen Inc., Thousand Oaks, CA; 2001."},{"issue":"21","key":"655_CR8","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","volume":"361","author":"MA Pfeffer","year":"2009","unstructured":"Pfeffer MA, Burdmann EA, Chen CY, et al. A trial of darbepoetin alfa intype 2 diabetes and chronic kidney disease. N Engl J Med. 2009;361(21):2019\u201332.","journal-title":"N Engl J Med"},{"issue":"20","key":"655_CR9","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa062276","volume":"355","author":"TB Dr\u00fceke","year":"2006","unstructured":"Dr\u00fceke TB, Locatelli F, Clyne N, et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med. 2006;355(20):2071\u201384.","journal-title":"N Engl J Med"},{"key":"655_CR10","unstructured":"U.S. National Institutes of Health. HIF inhibitor. ClinicalTrials.gov. \n                    http:\/\/www.clinicaltrials.gov\n                    \n                  . Accessed Sep 18, 2017."},{"key":"655_CR11","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1007\/s12325-017-0508-9","volume":"34","author":"K Becker","year":"2017","unstructured":"Becker K, Saad M. A new approach to the management of anemia: a review on roxadustat. Adv Ther. 2017;34:848\u201353.","journal-title":"Adv Ther."},{"issue":"2","key":"655_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/cpdd.83","volume":"3","author":"BM Johnson","year":"2014","unstructured":"Johnson BM, Stier BA, Caltabiano S. Effect of food and gemfibrozil on the pharmacokinetics of the novel prolyl hydroxylase inhibitor GSK1278863. Clin Pharmacol Drug Dev. 2014;3(2):109\u201317.","journal-title":"Clin Pharmacol Drug Dev."},{"key":"655_CR13","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.dmpk.2015.08.004","volume":"30","author":"K Hara","year":"2015","unstructured":"Hara K, Takahashi N, Wakamatsu A, Caltabiano S. Pharmacokinetics, pharmacodynamics and safety of single, oral doses of GSK1278863, a novel HIF-prolyl hydroxylase inhibitor, in healthy Japanese and Caucasian subjects. Drug Metab Pharmacokinet. 2015;30:410\u20138.","journal-title":"Drug Metab Pharmacokinet"},{"key":"655_CR14","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1681\/ASN.2014111139","volume":"27","author":"L Holdstock","year":"2016","unstructured":"Holdstock L, Meadowcroft AM, Maier R, et al. Four-week studies of oral hypoxia-inducible factor-prolyl hydroxylase inhibitor GSK1278863 for treatment of anemia. J Am Soc Nephrol. 2016;27:1234\u201344.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"655_CR15","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1053\/j.ajkd.2015.11.021","volume":"67","author":"R Brigandi","year":"2016","unstructured":"Brigandi R, Johnson B, Oei C, et al. A novel hypoxia-inducible factor-prolyl hydroxylase inhibitor (GSK 1278863) for anemia in CKD: a 28-day, phase 2A randomized trial. Am J Kidney Dis. 2016;67(6):861\u201371.","journal-title":"Am J Kidney Dis"},{"key":"655_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000454818","volume":"45","author":"T Akiwaza","year":"2017","unstructured":"Akiwaza T, Tsubakihara Y, Nangaku M, et al. Effects of daprodustat, a novel hypoxia-inducible factor prolyl hydroxylase inhibitor on anemia management in japanese hemodialysis subjects. Am J Nephrol. 2017;45:127\u201335.","journal-title":"Am J Nephrol"},{"issue":"6","key":"655_CR17","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1177\/1358863X14557151","volume":"19","author":"E Olson","year":"2014","unstructured":"Olson E, Demopoulos L, Haws TF, et al. Short-term treatment with a novel HIF-prolyl hydroxylase inhibitor (GSK1278863) failed to improve measures of performance in subjects with claudication-limited peripheral artery disease. Vasc Med. 2014;19(6):473\u201382.","journal-title":"Vasc Med."}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-017-0655-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-017-0655-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-017-0655-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T19:29:47Z","timestamp":1548098987000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-017-0655-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,28]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["655"],"URL":"https:\/\/doi.org\/10.1007\/s12325-017-0655-z","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,28]]},"assertion":[{"value":"31 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2017","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}